Vietnam Orient Commercial Joint Stock Bank expects its market capitalization to rise to $1 billion after its planned listing on the country’s benchmark bourse during the second half of the year, according to Chairman Trinh Van Tuan.
The 22-year-old bank, also known as OCB, plans to list 750 million shares on the Ho Chi Minh City Stock Exchange late third quarter or early fourth quarter, said Tuan, who would not disclose the planned initial price.
The bank plans to sell 800 billion dong ($35 million) of shares to investors via private placement in the third quarter after issuing 14.2 percent of dividend shares and 20.5 percent of shares to existing shareholders, Tuan said in his Ho Chi Minh City office Friday. OCB expects to boost its registered capital by 50 percent to 7.5 trillion dong through the share issuances before its planned listing, the chairman said.
The lender also plans to offer as much as 25 percent of its shares to foreign investors before the listing, according to Tuan.
Top 5 Bank Stocks To Own Right Now: Smart(SFS)
- [By Shane Hupp]
Smart & Final (NYSE: SFS) and Kroger (NYSE:KR) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.
- [By Lisa Levin]
Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
Arcadia Biosciences, Inc. (N
Top 5 Bank Stocks To Own Right Now: Google Inc.(GOOG)
- [By ]
That’s how companies like Alphabet (Nasdaq: GOOG), Amazon (Nasdaq: AMZN), Tencent (OTC: TCEHY), and Facebook (Nasdaq: FB) have grown so big. More importantly, it’s the reason Yahoo! died and Twitter (NYSE: TWTR) is running out of time.
- [By ]
Other large-cap stocks that have had similar levels of extreme shorting include Jim Cramer’s Action Alerts PLUS Charitable Trust Portfolio holding Alphabet Inc. (GOOG) (GOOGL) (then Google) back in late 2004 – shares rallied 112.5% in the year that followed.
- [By JJ Kinahan]
The key earnings report today comes from Alphabet Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL) after the close. For Q1, GOOGL is expected to report adjusted EPS of $9.21, up from $7.73 in the prior-year quarter, on revenue of $24.29 billion, according to third-party consensus estimates (revenue estimates are on a net basis excluding traffic acquisition costs). Revenue is projected to grow 20.7 percent year over year, while coming in shy of Q4 2017’s $25.9 billion, which is typically the company’s busiest quarter.
- [By ]
Waymo, the self-driving business unit from Alphabet Inc. (GOOG) (GOOGL) , a holding in Jim Cramer’s Action Alerts PLUS Charitable Trust Portfolio, is aiming for Level 5 driving, as is General Motors Co (GM) , with its plans for a fleet of self-driving taxis. While this sci-fi concept seems a long ways off, some argue that GM could have its robo-taxis on the road as early as 2019.
- [By Keith Speights]
However, I think the response passengerstake on an airplane that’s about to encounter a rough patch is the right approach for investors: Fasten your seat belts, sit back, and wait. That’s exactly what I plan to do, especially with three of my favorite growth stocks — Align Technology (NASDAQ:ALGN), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL), and NVIDIA (NASDAQ:NVDA). Here’s why I’m holding onto these stocks no matter how bumpy the market gets.
Top 5 Bank Stocks To Own Right Now: ImmunoGen, Inc.(IMGN)
- [By Logan Wallace]
ImmunoGen (NASDAQ:IMGN) was downgraded by BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued on Wednesday.
- [By George Budwell]
Shares of the clinical-stage biotech ImmunoGen (NASDAQ:IMGN) rose by as much as 13.8% on heavy volume in early-morning trading today. The catalyst?
- [By Lisa Levin] Gainers
Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
- [By Joseph Griffin]
Trexquant Investment LP raised its stake in shares of ImmunoGen (NASDAQ:IMGN) by 190.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 331,215 shares of the biotechnology company’s stock after buying an additional 217,244 shares during the quarter. Trexquant Investment LP owned about 0.25% of ImmunoGen worth $3,484,000 at the end of the most recent reporting period.
- [By Brian Orelli]
ImmunoGen (NASDAQ:IMGN) is in waiting mode with its lead drug, mirvetuximab, being tested in the phase 3 Forward I trial in patients with ovarian cancer, making for a relatively quiet first-quarter earnings release.
Top 5 Bank Stocks To Own Right Now: Citrix Systems Inc.(CTXS)
- [By Ethan Ryder]
CIBC Asset Management Inc lowered its stake in shares of Citrix Systems (NASDAQ:CTXS) by 5.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,564 shares of the cloud computing company’s stock after selling 1,023 shares during the period. CIBC Asset Management Inc’s holdings in Citrix Systems were worth $1,816,000 as of its most recent filing with the Securities & Exchange Commission.
- [By VantagePoint]
Citrix Systems, Inc. (NASDAQ: CTXS) had a very clear crossover to the upside on April 11, and since that day's close the stock is up 15 percent. This one is interesting also because the two moving averages have also recently diverged even further, indicating that the uptrend has only gotten stronger since the company posted an excellent Q1 earnings and Q2 guidance report that came in well above Wall Street's expectations.
- [By Ethan Ryder]
LogMeIn (NASDAQ: LOGM) and Citrix Systems (NASDAQ:CTXS) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.
- [By Asit Sharma]
Stock in digital workspace systems providerCitrix Systems, Inc. (NASDAQ:CTXS) rose 10.8% inApril, according to data fromS&P Global Market Intelligence.
- [By Max Byerly]
Here are some of the news stories that may have effected Accern Sentiment Analysis’s rankings:
Get Citrix Systems alerts:
Citrix Systems (CTXS) VP Jessica Soisson Sells 3,281 Shares (americanbankingnews.com) Glancy Prongay & Murray LLP Continues Investigation on Behalf of Citrix Systems, Inc. (CTXS) Investors (bizjournals.com) Glancy Prongay & Murray LLP Continues Investigation on Behalf of Citrix Systems, Inc.(CTXS) Investors (markets.financialcontent.com) Citrix Michael Lewis Day 3 Highlights from Synergy 2018 (dabcc.com) Citrix Certification Guide: Overview and Career Paths (businessnewsdaily.com)
A number of brokerages have commented on CTXS. Mizuho reaffirmed a “buy” rating on shares of Citrix Systems in a report on Wednesday, May 9th. Zacks Investment Research raised Citrix Systems from a “hold” rating to a “strong-buy” rating and set a $118.00 price objective on the stock in a report on Tuesday, May 1st. Goldman Sachs raised Citrix Systems from a “buy” rating to a “conviction-buy” rating in a report on Tuesday, May 1st. Royal Bank of Canada upped their price objective on Citrix Systems to $104.00 and gave the company a “market perform” rating in a report on Thursday, April 26th. Finally, Barclays upped their price objective on Citrix Systems from $90.00 to $100.00 and gave the company an “equal weight” rating in a report on Thursday, April 26th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, six have given a buy rating and three have given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $102.31.
Top 5 Bank Stocks To Own Right Now: Sonoco Products Company(SON)
- [By Ethan Ryder]
Packaging Co. of America (NYSE: PKG) and Sonoco (NYSE:SON) are both industrial products companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.
- [By Ethan Ryder]
Sonoco (NYSE: SON) and Packaging Co. of America (NYSE:PKG) are both industrial products companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation.